131 I-Meta-iodobenzylguanidine followed by busulfan and melphalan and autologous stem cell rescue in high-risk neuroblastoma.

Stefano GiardinoArnoldo PiccardoMassimo ConteMatteo PuntoniEnrica BertelliStefania SorrentinoMariapina MonteraMarco RissoIlaria CavigliaVania AltrinettiEdoardo LaninoMaura FaraciAlberto Garaventa

Published in: Pediatric blood & cancer (2020)

Th-131 I-MIBG administered shortly before HD-BuMel is a safe and effective regimen for patients with advanced MIBG-avid NB. These patients should be managed in centers with proven expertise.

Keyphrases

stem cells
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
high dose
peritoneal dialysis
prognostic factors
bone marrow
low dose
acute myeloid leukemia
acute lymphoblastic leukemia